Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells

25 May 2018

Abstract excerpt

// Atif J. Khan 1, 2 , Sarah M. Misenko 3 , Aditya Thandoni 2 , Devora Schiff 2 , Sachin R. Jhawar 2 , Samuel F. Bunting 3 and Bruce G. Haffty 2 1 Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10011, USA 2 Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA 3 Department of Molecular Biology and Biochemistry, Rutgers, The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell death mechanisms and regulation
Share to DNA Repair Mechanisms
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29899825
DOI: 10.18632/oncotarget.25383

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cellsPMID 29899825Read ↗

The PI3K/mTOR Inhibitor Ompalisib Suppresses Nonhomologous End Joining and Sensitizes Cancer Cells to Radio- and ChemotherapySemantic proximity Read ↗

Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatmentSemantic proximity Read ↗

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistanceSemantic proximity Read ↗

Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells.Semantic proximity Read ↗

Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer’s Achilles’ HeelSemantic proximity Read ↗

Modernizing the Nonhomologous End-Joining Repertoire: Alternative and Classical NHEJ Share the StageSemantic proximity Read ↗

The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and CancerSemantic proximity Read ↗

TFU72 is a novel and potent DNA-PKcs inhibitor for enhancing homology-directed repair gene editingSemantic proximity Read ↗

Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joiningSemantic proximity Read ↗

Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break RepairSemantic proximity Read ↗

Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectivesSemantic proximity Read ↗

Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.